About Cardinor

CardiNor is a Norwegian diagnostics company focused on the biomarker secretoneurin (SN). The company was founded in 2015, is fully owned by IC Targets, and is located in Oslo, sharing laboratory facilities with Pre Diagnostics.

SN addresses a medical unmet need by providing prognostic insight and risk stratification of patients with cardiovascular disease. The foundational research establishing SN as a cardiovascular biomarker was conducted in collaboration with leading clinical authorities at Akershus University Hospital, Oslo University Hospital, and Uppsala University Hospital.

The company has established an extensive network of key opinion leaders in the field that has provided CardiNor with access to large international, renowned clinical cohorts for the documentation and validation of the secretoneurin. Supported by the Norwegian Research Council, the company has commercialised a CE-IVD SN ELISA assay. The company is on track with its bead-based SN assay for high-throughput testing platforms, soon available as research-use-only and on the path to IVDR.